OMEGA-3-FATTY-ACIDS - ESSENTIAL FATTY-ACIDS WITH IMPORTANT BIOLOGICAL EFFECTS, AND SERUM PHOSPHOLIPID FATTY-ACIDS AS MARKERS OF DIETARY OMEGA-3-FATTY-ACID INTAKE

被引:119
|
作者
BJERVE, KS
BRUBAKK, AM
FOUGNER, KJ
JOHNSEN, H
MIDTHJELL, K
VIK, T
机构
[1] UNIV HOSP TRONDHEIM, DEPT PEDIAT, TRONDHEIM, NORWAY
[2] INST PUBL HLTH, CTR COMMUNITY MED, VERDALSORA, NORWAY
关键词
DIABETES-MELLITUS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; FISH OIL; MENTAL AND PSYCHOMOTOR DEVELOPMENT; OMEGA-3 POLYUNSATURATED FATTY ACIDS; PLASMA PHOSPHOLIPID FATTY ACIDS; PRETERM INFANTS; VERY-LOW-BIRTH-WEIGHT INFANTS;
D O I
10.1093/ajcn/57.5.801S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Serum phospholipid eicosapentaenoic (PL-EPA) and docosahexaenoic acid (PL-DHA) concentrations are associated with the dietary intake of omega3 fatty acids. PL-EPA and PL-DHA concentrations measured 4 y apart in 211 diabetic patients were highly correlated, with Spearman correlation coefficients of 0.49 (p = 0.0001) and 0.64 (p = 0.0001), respectively. PL-DHA was positively associated with Bayley psychomotor and mental developmental indexes (PDI and MDI, respectively) in preterm infants. Using multiple-regression analysis, 64% (R2 = 0.639; p = 0,0001) of PDI variance was explained by 1/DHA and weight at 1 y, whereas 82% (R2 = 0.816; p = 0.0001) of MDI variance was explained by weight at 1 y, Apgar score, 1/DHA, and 1/EPA. 1/DHA was negatively correlated with PDI and MDI, whereas 1/EPA was positively correlated with MDI. The results suggest that infant formulas should contain preformed DHA, and that a too-high supply of EPA in addition to DHA might be harmful in preterm infants.
引用
收藏
页码:801 / 806
页数:6
相关论文
共 50 条
  • [41] Omega-3 Fatty Acids in the Management of Epilepsy
    Tejada, Silvia
    Martorell, Miquel
    Capo, Xavier
    Tur, Josep A.
    Pons, Antoni
    Sureda, Antoni
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (17) : 1897 - 1905
  • [42] Omega-3 fatty acids and blood pressure
    Cabo, Jorge
    Alonso, Rodrigo
    Mata, Pedro
    BRITISH JOURNAL OF NUTRITION, 2012, 107 : S195 - S200
  • [43] Omega-3 fatty acids and cardiovascular disease
    von Schacky, Clemens
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (02) : 129 - 135
  • [44] Neurological Benefits of Omega-3 Fatty Acids
    Dyall, S. C.
    Michael-Titus, A. T.
    NEUROMOLECULAR MEDICINE, 2008, 10 (04) : 219 - 235
  • [45] The Impact of Omega-3 Fatty Acids on Osteoporosis
    Maggio, M.
    Artoni, A.
    Lauretani, F.
    Borghi, L.
    Nouvenne, A.
    Valenti, G.
    Ceda, G. P.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (36) : 4157 - 4164
  • [46] Omega-3 Polyunsaturated Fatty Acids and Cancer
    Jing, Kaipeng
    Wu, Tong
    Lim, Kyu
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (08) : 1162 - 1177
  • [47] Neurological Benefits of Omega-3 Fatty Acids
    S. C. Dyall
    A. T. Michael-Titus
    NeuroMolecular Medicine, 2008, 10 : 219 - 235
  • [48] The guardians of macular health: Omega 3 fatty acids
    Varre, Joseph V.
    Daniel, Noel
    Ryoo, Wonjong
    van Vliet, Stephan
    PHARMANUTRITION, 2024, 29
  • [49] Omega-3 fatty acids in critical illness
    Martin, Julie M.
    Stapleton, Renee D.
    NUTRITION REVIEWS, 2010, 68 (09) : 531 - 541
  • [50] Omega-3 fatty acids and hypertension in humans
    Mori, Trevor A.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (09) : 842 - 846